About conference :

Longdom Conferences extends our immense pleasure and honor to invite you to attend the "3^rd International Conference on Hypertension and Patient care" on Dec 12-13, 2022 in New York, USA. Hypertension Conference mainly focuses on the theme “Measure your blood pressure, control it, and live longer.” The agenda will address some of the major issues related to Hypertension and its related subjects to establish a connection for exchanging ideas. Our conference agenda is to present keynote talks, plenary sessions, discussion panels, Poster Presentations, symposia, young researcher’s forums, video Presentations, and Workshops.

Hypertension and Patient Care is comprised of various tracks and sessions designed to offer comprehensive sessions that address current issues in the field of Hypertension and Patient care

Scientific Sessions:

Sessions 1: Hypertension

Hypertension is a chronic disease. It can be controlled with medication, but it cannot be cured. Due to the lack of noticeable symptoms, hypertension is a silent health condition. The only way of knowing the problem is to check your blood pressure. Hence the patients need to continue with the treatment and lifestyle modifications as advised by their doctor, and attend regular medical follow up, usually for life. To examine current patterns of Hypertension (HTN) treatment, including blood pressure (BP) control, prevalence of different antihypertensive agents, and variations in treatment associated with patient and Physician characteristics. Hypertension Conference is covering the topics such as Secondary Hypertension, Hypertension Rheumatoid Arthritis, Oncology and Blood Pressure, Genetic Factors of Hypertension, Life Style of High Blood Pressure.

Sessions 2: Pulmonary & Arterial hypertension

Pulmonary Hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. The most relevant mechanisms for sudden cardiac death in PAH patients seem to be related to severe dilatation of the pulmonary artery, as subsequent complications, such as left main compression syndrome, Pulmonary artery dissection, Pulmonary artery rupture, and Massive hemoptysis, may take place.

Sessions 3: Pediatric Hypertension

In the pediatric population, Hypertension is more commonly observed which is the major cause of mortality and morbidity in many countries. And long-term health risk to children. It is also noted that there is a correlation between overweight obesity and hypertension and also blood pressure of parents and that of their offspring. Obese children have 3 fold risk of getting hypertension than that of no obese. Children with hypertension should also be screened for Cardiovascular disease, including Diabetes mellitus and Hyperlipidaemia, and should be evaluated for target organ damage with a retinal examination and echocardiography.

Sessions 4: Resistance Hypertension

Resistance hypertension is high blood pressure that does not respond well to aggressive medical treatment. It is defined as failure to achieve goal blood pressures in patients taking optimal or maximum tolerated doses of three or more antihypertensive drugs, is estimated to occur in about 25% of hypertensive patients on treatment. Several factors have been identified as contributors to resistant hypertension. Poor patient adherence, physician inertia, inadequate doses or inappropriate combinations of antihypertensive drugs, excess alcohol intake, and volume overload are some of the most common causes of resistance.

Sessions 5: Renal/ Renovascular Hypertension

Renal /Renovascular hypertension caused by a narrowing of the arteries which convey blood to the kidney and which can be controlled by circulatory strain drugs. Individuals with renal hypertension can benefit from outside assistance by stenting, angioplasty, or surgery on the veins of the kidney. Renal hypertension mirrors the connection between blood vessel occlusive sickness and hoisted pulse. More particular determinations are made reflectively when hypertension enhances after intravascular intercession.

Sessions 6: Gestational Hypertension

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy).

Sessions 7: Heart & Cardiovascular diseases

All heart diseases are Cardiovascular diseases, but not all cardiovascular diseases are heart disease. The most common type of heart disease is coronary heart disease. Cardiovascular disease (CVD) is a class of diseases that involve the Heart or blood vessels. The treatment for heart disease usually includes lifestyle changes.
Heart conditions caused by high blood pressure known as Hypertensive heart disease. Heart problems associated with high blood pressure related to the heart arteries and muscles include narrowing of the arteries called Coronary Heart Disease(CHD) and Thickening and enlargement of the heart called Left Ventricular Hypertrophy(LVH).

Market Analysis

As per a statement of the World Health Organization (WHO), Hypertension is one of the silent killers in the 21st century and is one of the biggest global public health concerns. Hypertension is a major contributor to cardiac complications, stroke, heart diseases, kidney failure, blindness, including premature death and disabilities. Hypertension is curable as well as treatable for which there is a need for involvement from individual entities, government and private sectors, health workers, civil societies, and moreover individual awareness is highly recommended.

As per the estimation of WHO, globally more than 1.13 billion people are affected with Hypertension among which less than 1 in each 5 is under control. Unfortunate eating regimens, absence of physical exercises, utilization of liquor, and tobacco are the fundamental contributing elements of Hypertension. To lessen the predominance by 25% by 2025, WHO alongside the United States Center for Disease Control and Prevention dispatched the Global heart Initiative in 2016. Globally, Hypertension or High Blood Pressure leads to 7.5million death cases which share about 12.8% of all death cases recorded. Hypertension is also accounted for about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & hemorrhagic stroke.

The global prevalence of Hypertension in adults aged>25 was about 40% in 2008. Between 1980 to 2008 the prevalence was moderate. But, due to the sharp growth in population, the aging population the uncontrolled Hypertension reached 1 billion in 2008 from 600 million. The prevalence of hypertension was highest in Africa (>40%) and lower in the Americas (35%).

As per the research of some independent firms, the global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. The main drugs in the Hypertension market are Tacleer, Uptravi, Opsumit, Letairis, Adcirca, Revatio, Adempas, Veletri, Oremitram, Tyvaso, Remodulin. Major classes of drugs used are Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin-Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors. Major players in the antihypertensive drugs market are: Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Sanofi Aventis, and United Therapeutics.

Past Conferences Report

Emergency Mediccine and Critical Care 2020

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Critical care and Emergency Medicine 2020 Webinar the best ever!

Annual Congress on Emergency Medicine and Critical Care, hosted by the Longdom Conference was held during June22, 2020 at London, UK based on the theme “Annual Congress on Emergency Medicine and Critical Care".

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr. Abdel Rahman Tawfik, mohammed bin rashid university, Dubai.
Dr. Rumana Omar, university college london
Dr. Vahitha Abdul Salam, queen mary university of london
Dr. Evangelia Michail Michailidou, University of Macedonia.
Dr. Manda Venkatramana, Gulf Medical University.

For More details about our Previous Summit visit: https://www.longdom.com/emergency-criticalcare-2021

With the grand success of Emergency Medicine and Critical care 2020, Longdom Conferences is proud to announce the "3rd International Conference on Hypertension" to be held April 19-20, 2022 at Tokyo, Japan.

Cardiology and Cardiovascular Medicine 2021

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Cardiology 2021 the best ever!

Cardiology and Cardiovascular Medicine hosted by the Longdom Conference was held during Nov 12-12,2021 at New York, USA based on the theme “Keys to Keep Your Heart Healthy".

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr. Faten Mahmoud Ali Diab, Gulf Medical University, El-Garf, Ajman, UAE.
Dr. Jaroslaw Nowacki, Queen Mary’s Hospital Sidcup, Hurley Medical Group.
Dr. Chavi Tejpal, Windsor University School of Medicine.
Dr. Evangelia Michail Michailidou, University of Macedonia.
Dr. Dennis Adjepong, Poznan University of Medical Science, Poland.

For More details about our Previous Summit visit: https://www.longdom.com/cardiology-2021

Interventional Cardiology 2021

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Interventional Cardiology 2021 Webinar the best ever!

International Webinar on Interventional Cardiology, hosted by the Longdom Conference was held during Sep 24-25, 2021,Vienna, Austria based on the theme “Latest Techniques and Strategies in Interventional Cardiology".

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr. Saleem Ahmed, university of Pittsburgh, USA.
Dr. Rosa M Mendizabal-Espinosa, university college London.
Dr. Vahitha Abdul Salam, queen mary university of London
Dr. Evangelia Michail Michailidou, University of Macedonia.
Dr. Dennis Adjepong, Poznan University of Medical Science, Poland.

For More details about our Previous Summit visit: https://www.longdom.com/interventional-cardiology-2021

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter